Skip to main content
. 2022 Dec 30;20(7):1809–1818. doi: 10.1111/ajt.15915

TABLE 7.

Number of respondents who reported changes in immunosuppression for COVID-19–SOT patients

Kidney
n = 26
n (%)
Liver
n = 12
n (%)
Heart
n = 2
n (%)
Lung
n = 4
n (%)
Antimetabolitea
Reduce 5 (19.2) 2 (16.7) 0 1 (25.0)
Stop 24 (92.3) 8 (66.7) 1 (50.0) 1 (25.0)
Calcineurin inhibitorsb
Reduce 7 (26.9) 2 (16.7) 1 (50.0) 0
Stop 4 (15.4) 1 (8.3) 0 1 (25.0)
Steroids
Reduce 2 (7.7) 0 0 0

Note: Respondents could respond to more than one answer.

a

Includes mycophenolate mofetil (MMF).

b

Includes mTOR inhibitors.